Indoor Harvest (INQD) 10-Q 14 Aug 17 2017 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Aug. 14, 2017
Document And Entity Information [Abstract]
Entity Registrant Name	Indoor Harvest Corp
Entity Central Index Key	1,572,565
Trading Symbol	inqd
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		16,823,352
Document Type	10-Q
Document Period End Date	Jun. 30, 2017
Amendment Flag	false
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2

BALANCE SHEETS (UNAUDITED)

BALANCE SHEETS (UNAUDITED) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash	$ 59,644	$ 78,219
Accounts receivable		34,853
Other receivable	7,323	7,323
Inventory	2,360	2,360
Prepaid expenses	8,632
Total current assets	77,959	122,755
Furniture and equipment, net	133,568	158,418
Security deposit	12,600	12,600
Intangible asset, net	6,750	7,604
Total assets	230,877	301,377
Current liabilities:
Accounts payable and accrued expenses	53,820	55,797
Convertible note payable, net of debt discount of $72,200 and $152,617, respectively	202,800	122,383
Note payable, net of discount of $0 and $15,714, respectively		209,786
Accrued payroll	3,722	7,142
Deferred rent	7,376	8,513
Note payable - current portion	7,714	6,790
Billing in excess of costs and estimated earnings		20,155
Total current liabilities	275,432	430,566
Long term liabilities:
Note payable	16,110	20,342
Total liabilities	291,542	450,908
STOCKHOLDERS' DEFICIT
Series, A Convertible Preferred stock: $0.01 par value, 5,000,000 shares authorized; 750,000 and 250,000 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively	7,500	2,500
Common stock: $0.001 par value, 50,000,000 shares authorized; 19,323,352 and 15,213,512 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively	19,323	15,213
Additional paid-in capital	5,689,920	3,829,528
Accumulated deficit	(5,777,408)	(3,996,772)
Total stockholders' deficit	(60,665)	(149,531)
Total liabilities and stockholders' deficit	$ 230,877	$ 301,377

BALANCE SHEETS (UNAUDITED) (Par

BALANCE SHEETS (UNAUDITED) (Parentheticals) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Debt discount on convertible note payable (in dollars)	$ 72,200	$ 152,617
Discount on note payable (in dollars)	$ 0	$ 15,714
Series A, Convertible Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Series A, Convertible Preferred Stock, shares authorized	5,000,000	5,000,000
Series A, Convertible Preferred Stock, shares issued	750,000	250,000
Series A, Convertible Preferred Stock, shares outstanding	750,000	250,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	19,323,352	15,213,512
Common stock, shares outstanding	19,323,352	15,213,512

STATEMENTS OF OPERATIONS (UNAUD

STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Revenue		$ 39,872		$ 62,166
Cost of sales	$ 2,694	27,122	$ 14,429	43,921
Gross profit (loss)	(2,694)	12,750	(14,429)	18,245
Operating expenses
Depreciation and amortization expense	13,112	12,690	26,254	25,263
Research and development	887	5,641	1,625	8,672
Professional fees	276,361	18,650	366,908	75,922
General and administrative expenses	130,099	391,281	752,497	634,739
Total operating expenses	420,459	428,262	1,147,284	744,596
Loss from operations	(423,153)	(415,512)	(1,161,713)	(726,351)
Other income (expense)
Other income (expense)	9		11
Loss on investment in joint venture	(250,000)		(250,000)
Interest expense	(6,546)	(100,334)	(119,232)	(111,185)
Amortization of debt discount	(44,695)		(249,702)
Total other income (expense)	(301,232)	(100,334)	(618,923)	(111,185)
Net loss	$ (724,385)	$ (515,846)	$ (1,780,636)	$ (837,536)
Net loss per common share:
Net loss per share, basic and diluted (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.10)	$ (0.07)
Weighted average number of common shares outstanding:
Basic and diluted (in shares)	19,153,022	12,015,234	17,991,073	11,799,280

STATEMENTS OF SHAREHOLDERS' EQU

STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - 6 months ended Jun. 30, 2017 - USD ($)	Series A Convertible Preferred Stock, $0.01 Par Value	Common Stock, $0.001 Par Value	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2016	$ 2,500	$ 15,213	$ 3,829,528	$ (3,996,772)	$ (149,531)
Balance (in shares) at Dec. 31, 2016	250,000	15,213,512
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash		$ 2,060	821,940		824,000
Issuance of common stock for cash (in shares)		2,060,000
Issuance of common stock for services, net of debt offering costs		$ 1,300	515,630		516,930
Issuance of common stock for services, net of debt offering costs (in shares)		1,299,840
Convertible debt converted into common stock		$ 333	99,667		100,000
Convertible debt converted into common stock (in shares)		333,333
Beneficial conversion feature			95,333		95,333
Conversion of preferred stock into common shares	$ (2,500)	$ 417	35,321		33,238
Conversion of preferred stock into common shares (in shares)	(250,000)	416,667
Preferred stock for cash	$ 7,500		292,501		300,001
Preferred stock for cash (in shares)	750,000
Net loss for the six months ended June 30, 2017				(1,780,636)	(1,780,636)
Balance at Jun. 30, 2017	$ 3,000	$ 19,323	$ 5,689,920	$ (5,777,408)	$ (60,665)
Balance (in shares) at Jun. 30, 2017	750,000	19,323,352

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (1,780,636)	$ (837,536)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	26,254	25,263
Amortization of original issue discount		12,229
Amortization of debt discount	249,702	83,922
Amortization of debt offering costs		10,869
Stock issued for services - related party	109,930	143,527
Stock issued for services	407,000	119,216
Change in operating liability:
Decrease in deferred rent	(1,137)	(127)
(Increase) Decrease in accounts receivable	34,853	59,200
Increase in inventory		2,104
Increase in prepaid expense	(8,632)	(13,820)
(Decrease) Increase in accounts payable and accrued expenses	(1,977)	19,708
Decrease in accrued payroll	(3,420)	4,327
Increase in costs and estimated earnings in excess of billings	(20,155)	33,504
Decrease in accrued compensation		(961)
Net cash used in operating activities	(988,218)	(338,575)
Cash flows from investing activities:
Purchase of equipment and software	(550)	(5,798)
Net cash used in investing activities	(550)	(5,798)
Cash flows from financing activities:
Repayments of note payable	(228,807)	(2,987)
Proceeds from convertible note payable, less offerings costs and OID costs paid		230,000
Repayment of convertible note	(175,000)
Proceeds from demand note payable, less OID costs paid	250,000
Issuance of preferred stock for cash and warrants	300,000
Issuance of common stock for cash	824,000	50,000
Net cash provided by financing activities	970,193	277,013
Increase cash and cash equivalents	(18,575)	(67,360)
Cash and cash equivalents at beginning of period	78,219	100,906
Cash and cash equivalents at end of period	59,644	33,546
Cash paid during the period for:
Interest	1,321	1,642
Income taxes
Supplemental disclosure of non-cash investing and financing activities:
Beneficial conversion feature	95,333	154,416
Shares issued for debt issuance costs		$ 143,500
Settlement of convertible note into common shares	100,000
Conversion of preferred shares into common shares	$ 2,500

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (GAAP). It is management's opinion, however, that all material adjustments (consisting of normal and recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. Indoor Harvest Corp., or the "Company," is a Texas corporation formed on November 23, 2011. Indoor Harvest Corp., through its brand name Indoor Harvest™, is a company specializing in equipment design, development, marketing and direct-selling of commercial grade aeroponics fixtures and supporting systems for use in urban Controlled Environment Agriculture ("CEA") and Building Integrated Agriculture ("BIA"). Indoor Harvest Corp transitioned in the first half of 2017 from an Engineering, Procurement and Construction Management Company for the vertical farming industry, into a developer of personalized cannabis medicines, and a provider of advanced cultivation technology, methods and processes for cannabis production. These unaudited interim condensed financial statements should be read in conjunction with the financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2016, filed with the SEC on April 17, 2017. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited to the estimate of percentage of completion on construction contracts in progress at each reporting period which we rely on as a primary basis of revenue recognition, estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities. Cash and Cash Equivalents The Company considers all highly liquid instruments with a maturity of three months or less to be cash and cash equivalents. Accounts Receivable and Work in Progress Work in process consists of costs recorded and revenue earned on projects recognized on the percentage of completion method for work performed on contracts in progress at June 30, 2017 and December 31, 2016. The Company records revenue based on contractual agreements entered into at the inception of construction contracts. Amounts are payable from customers based on milestones established in each contract. Amounts are billed at milestone completion and are reflected as accounts receivable when billed. Costs and estimated earnings are accumulated on projects in process and compared to amounts billed based on the percentage of completion method of accounting (cost to cost). Costs incurred in excess of amounts billed and related profit recognized are reflected as an asset in the balance sheet as costs and estimated earnings in excess of billings. Unearned billings are reflected in the balance sheet as a liability as billings in excess of costs and estimated earnings on projects in process (See Note 6). Inventories Inventory consists primarily of raw materials and packaging materials and is valued at the lower of cost or market. Cost is determined using the weighted average method and average cost is recomputed after each inventory purchase or sale. Inventory is periodically reviewed to identify obsolete or damaged inventory and impaired values. Inventory is comprised of raw materials such as steel for our framing systems and packaging materials such as boxes and pallets valued at $2,360 at both June 30, 2017 and December 31, 2016. Revenue Recognition The Company recognizes revenue on arrangements in accordance with ASC No. 605, Revenue Recognition. In all cases, revenue is recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. The Company will generate revenue from the design and installation of the equipment. Revenue from construction contracts are reported under the percentage of completion method for financial statement purposes. The estimated revenue for each contract reflected in the financial statements represent that percentage of estimated total revenue that costs incurred to date bear to estimated total costs, based on the Company’s current estimates. With respect to contracts that extend over one or more accounting periods, revisions in costs and revenue estimates during the work are reflected in the period the revisions become known. When current estimates of total contract costs indicate a loss, provision is made for the entire estimated loss. The asset, “costs and estimated earnings in excess of billings on uncompleted contracts,” represents revenues recognized in excess of amounts billed. The liability, “Estimated earnings on uncompleted contracts,” represents billings in excess of revenues recognized. Billing practices for these projects are governed by the contract terms of each project based upon actual costs incurred, achievement of milestones, or pre-agreed schedules. Billings do not necessarily correlate with revenue recognized under the percentage of completion method of accounting. Except for claims and change orders that are in the process of being negotiated with customers, unbilled work is usually billed during normal billing processes following achievement of the contractual requirements. Stock Based Compensation The Company recognizes stock based compensation in accordance with ASC 718-10, Stock Compensation. ASC 718-10 focuses on transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus in which an entity obtains employee services in stock based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award (with limited exceptions). Basic Loss per Share Basic loss per share amounts are calculated based on the weighted average number of shares of common stock outstanding during each period. Diluted earnings per share is based on the weighted average numbers of shares of common stock outstanding for the periods, including dilutive effects of stock options, warrants granted and convertible preferred stock. Dilutive options and warrants that are issued during a period or that expire or are canceled during a period are reflected in the computations for the time they were outstanding during the periods being reported. Since the Company has incurred losses for all periods, the impact of the common stock equivalents would be antidilutive and therefore are not included in the calculation. The Company has the following common stock equivalents for the six months ended June 30, 2017 and 2016, respectively: June 30, June 30, Convertible debt (exercise price - $0.30/share) 916,667 908,333 Fair Value of Financial Instruments The Company adopted ASC 820 Fair Value Measurements for financial and non-financial assets and liabilities. The adoption did not have a material impact on our results of operations, financial position or liquidity. This standard defines fair value and provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share based payments. ASC 820 discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: · Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. · Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. · Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. Carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to their relatively short maturity. Debt classified as Level 2 in the fair value hierarchy represent note payable, net of debt discount, of $0 and $209,786 at June 30, 2017 and December 31, 2016, respectively, and convertible notes payable of $202,800 and $122,383 at June 30, 2017 and December 31, 2016, respectively. Income Taxes The Company accounts for income taxes pursuant to ASC 740 “Income Taxes,” which requires recognition of deferred income tax liabilities and assets for the expected future tax consequences of events that have been recognized in the financial statements or tax returns. The Company provides for deferred taxes on temporary differences between the financial statements and tax basis of assets using the enacted tax rates that are expected to apply to taxable income when the temporary differences are expected to reverse. ASC 740 establishes a more likely than not threshold for recognizing the benefits of tax return positions in the financial statements. Also, the statement implements a process for measuring those tax positions that meet the recognition threshold of being ultimately sustained upon examination by the taxing authorities. There are no uncertain tax positions taken by the Company on its tax returns. The Company files tax returns in the U.S. and states in which it has operations and is subject to taxation. Tax years 2016, 2015, 2014, 2013, 2012 and 2011, remain subject to examination by the IRS and respective states. Property and Equipment Property and equipment is recorded at cost and depreciated or amortized using the straight-line method over the estimated useful life of the asset or the underlying lease term for leasehold improvements, whichever is shorter. The estimated useful life by asset description is noted in the following table: Asset Description Estimated Useful Life (Years) Furniture and equipment 3 - 5 Tooling equipment 10 Leasehold improvements * __________ * The shorter of 5 years or the life of the lease. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in other income. Intangible Assets The Company's intangible assets consist of the domain name and is accounted for as an indefinite lived intangible asset in accordance with ASC 350 "Goodwill and Other Intangible Assets" ("ASC 350"). It also includes software and is amortized over a 3-5-year period. Intangible assets are reviewed annually for impairment or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no impairment charges taken during the six months ended June 30, 2017 and 2016. Intangible assets consist of the following at June 30, 2017 and December 31, 2016: Classification June 30, December 31, Domain name $ 2,000 $ 2,000 Facilities Manager's Package Online 1,022 1,022 MLC CD Systems (software) 7,560 7,560 Total 10,582 10,582 Less: Accumulated amortization (3,832 ) (2,978 ) Intangible assets, net $ 6,750 $ 7,604 Patent and Patent Application Expenses Although the Company believes that its patent and underlying technology will have continuing value, the amount of future benefits to be derived from the patent is uncertain. Therefore, patent costs are expensed as incurred. Research and Development Research and development expenditures are charged to expense as incurred. Research and development expense for the three and six months ended June 30, 2017 and 2016 are as follows: Three Months Ended Six Months Ended June 30, June 30, 2016 June 30, June 30, 2016 Research and development expense $ 887 $ 5,641 $ 1,625 $ 8,672 Advertising Expense Advertising and promotional costs are expensed as incurred. Advertising expense for the three and six months ended June 30, 2017 and 2016, are as follows: Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, Advertising expense $ 3,036 $ - $ 12,887 $ - Reclassifications Certain balance sheet items have been reclassified at December 31, 2016 to conform to the reporting format adopted at June 30, 2017. Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect as of the date of the issuance of these financial statements. The following pronouncements may impact future reporting of financial position and results of operations. Management is currently assessing implementation. The FASB issued Accounting Standards Update (ASU) No. 2017-01, Business Combinations (Topic 805) clarifying the definition of a business. The amendment affects all companies and other reporting organizations that must determine whether they have acquired or sold a business. For public companies, the amendment is effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) providing new lease accounting guidance. Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: · A lease liability, which is a lessee‘s obligation to make lease payments arising from a lease, measured on a discounted basis; and · A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. · Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic 606, Revenue from Contracts with Customers. · The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. Public business entities should apply the amendments in ASU 2016-02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (i.e., January 1, 2019, for a calendar year entity). The FASB has issued Accounting Standards Update (ASU) No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments are intended to improve the accounting for employee share-based payments and affect all organizations that issue share-based payment awards to their employees. Several aspects of the accounting for share-based payment award transactions are simplified, including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. For public companies, the amendments are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For private companies, the amendments are effective for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. Early adoption is permitted for any organization in any interim or annual period. The FASB issued Accounting Standards Update No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. The amendment clarifies the following two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The amendment does not change the core principle of the guidance in Topic 606. The effective date and transition requirements for the amendment is the same as the effective date and transition requirements in Topic 606. Public entities should apply the amendments for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein (i.e., January 1, 2018, for a calendar year entity). Early application for public entities is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The effective date for nonpublic entities is deferred by one year. Derivative Liability The Company accounts for derivative instruments in accordance with ASC 815 Derivatives and Hedging, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At June 30, 2017 and December 31, 2016, the Company did not have any derivative instruments that were designated as hedges. Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a "beneficial conversion feature" ("BCF") and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The discount is amortized to interest expense over the life of the debt.

GOING CONCERN

GOING CONCERN	6 Months Ended
	Jun. 30, 2017
Going Concern [Abstract]
GOING CONCERN	NOTE 2 - GOING CONCERN As reflected in the accompanying unaudited financial statements, the Company had a net loss of $1,780,636, net cash used in operations of $988,218 and has an accumulated deficit of $5,777,408, for the six months ended June 30, 2017. These factors raise substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on Management's plans which include potential asset acquisitions, mergers or business combinations with other entities, further implementation of its business plan and continuing to raise funds through debt or equity financings. The Company will likely rely upon related party debt or equity financing to ensure the continuing existence of the business. The Company’s business plan is to engage in the design and development of commercial grade aeroponics fixtures and supporting systems for use in CEA and BIA cannabis production and to develop personalized cannabis medicines, as a provider of advanced cultivation technology, methods and processes. The Company provides the cannabis industry production platforms for CEA and BIA production. During the next twelve months, the Company's strategy is to: · complete ongoing product development; · advance product assembly and sales; · construct a demonstration cannabis CEA and BIA farm for marketing purposes; · offer design-build services to partners; and · establish its long-term strategy to directly sell, license and franchise its patented cannabis cultivation technologies and methods. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	6 Months Ended
	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 3 - PROPERTY AND EQUIPMENT Property and equipment consist of the following at June 30, 2017 and December 31, 2016: Classification June 30, December 31, Furniture and equipment $ 124,379 $ 123,827 Tooling equipment 27,015 27,015 Leasehold improvements 57,780 57,780 Computer equipment 6,169 6,169 Research and development lab 63,177 63,177 Total 278,520 277,968 Less: Accumulated depreciation (144,952 ) (119,550 ) Property and equipment, net $ 133,568 $ 158,418 Depreciation expense for the six months ended June 30, 2017, totaled $25,402.

COMMITMENTS & CONTINGENCIES

COMMITMENTS & CONTINGENCIES	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS & CONTINGENCIES	NOTE 4 - COMMITMENTS & CONTINGENCIES Alamo CBD and Vyripharm Joint Venture On January 3, 2017, the Company signed a binding letter of intent with Alamo CBD, LLC (“Alamo CBD”) to enter discussions to combine and create a medical cannabinoids pharmaceutical group. Pursuant to the terms, the Company was required as a precondition, to raise, as necessary, up to $1,000,000 in capital by February 15, 2017, to pay off all existing debt, including convertible notes, owed by the Company. On February 15, 2017, the Company and Alamo CBD extended the terms of the preconditions until March 15, 2017. On March 23, 2017 (the “Effective Date”), the Company entered into a Contractual Joint Venture Agreement by and between Vyripharm Enterprises, LLC (“Vyripharm”) and Alamo CBD, collectively the Parties, pursuant to which the parties agreed to participate in an unincorporated joint venture (the “Joint Venture” or “JV”). The intent of the Joint Venture was for the Parties to work together to enhance the ability of Alamo CBD to apply for and obtain licensure, or a permit, to grow and/or dispense marijuana products for medical and/or consumer use: · In Texas, pursuant to the Texas Compassionate Use Act, as may be amended; · In Colorado, pursuant to recent Colorado legislation permitting foreign ownership of entities that grow and/or dispense marijuana products for medical and/or consumer use; and · Pursuant to recent United States Drug Enforcement Administration regulations which expand the Opportunities for entities providing research involving marijuana and its chemical constituents, as referenced in 21 U.S.C. 822(a)(1) and 21 U.S.C. 823(a), et. seq. · To establish Alamo CBD as a supplier of a variety of medical use cannabis oil to Vyripharm for Vyripharm’s use in conducting research and development to create novel pharmaceutical and radiopharmaceutical compounds designed to image and treat certain debilitating diseases including, but not limited to drug-resistant epilepsy, post-traumatic stress disorder, Alzheimer’s, ALS, and other neurodegenerative diseases; and · To establish Indoor Harvest as the project developer and engineering, procurement and construction group, in which Indoor Harvest would be responsible for costs and efforts related to Alamo CBD's efforts to become licensed under the Texas Compassionate Use Act and to meet its obligations under this Joint Venture agreement. The initial term of the Joint Venture as set forth in the JV Agreement was five (5) years following the Effective Date, and the JV Agreement could be extended beyond the Initial Term by mutual consent of the Parties. Pursuant to the JV Agreement, IHI agreed to contribute a total of $5,000,000 based on $1,000,000 per year for each of the first five (5) years of the Initial Term. The first payment of $1,000,000 would be paid to Vyripharm no later than four (4) days following the Effective Date, and the remaining four (4) annual payments would be paid by IHI to Vyripharm on each of the following one (1) year anniversaries of the Effective Date. As set forth in the JV Agreement, if IHI failed to timely pay the initial $1,000,000, the JV Agreement would terminate and neither Party would have further obligation to the other. If IHI failed to pay the second $1,000,000 payment within thirty (30) days following the second anniversary of the Effective Date, then the JV Agreement would terminate and Alamo CBD would forfeit four-fifths (4/5) of its revenue share from any product that had been developed or would be subsequently developed by Vyripharm using the cannabis oil and/or processes supplied to Vyripharm by IHI. If IHI failed to pay the third $1,000,000 payment within thirty (30) days following the third anniversary of the Effective Date, then the JV Agreement would terminate and IHI would forfeit three-fifths (3/5) of its revenue share from any product that had been developed or would subsequently be developed by Vyripharm using the medical cannabis oil and/or processes supplied to Vyripharm by IHI. If IHI fails to pay the fourth $1,000,000 payment within thirty (30) days following the fourth anniversary of the Effective Date, then the JV Agreement would terminate and IHI would forfeit four-fifths (2/5) of its revenue share from any product that had been developed or would be subsequently developed by Vyripharm using the medical cannabis oil and/or processes supplied to Vyripharm by IHI. If IHI fails to pay the fifth $1,000,000 payment within thirty (30) days following the fifth anniversary of the Effective Date, then the JV Agreement would terminate and IHI would forfeit one-fifth (1/5) of its revenue share from any product that had been developed or was subsequently developed by Vyripharm using the medical cannabis oil and/or processes supplied to Vyripharm by IHI. Except for cost sharing for the filing of, prosecuting and maintaining any joint patent applications pursuant to Paragraph 6 of this Agreement, and unless the Parties mutually agree, IHI will have no further financial obligations under the JV Agreement during the Initial Term, and the Parties must bear their own costs in carrying out their respective responsibilities under this Agreement. Note: Based on the described fees and schedule that Vyripharm must attain with the institutions in the TMC, the Company can only accept a payout structure of the first $1,000,000 under the following three scenarios: · Option 1: All $1,000,000 for the year will be paid to Vyripharm in advance if excess funds are raised (above $10,250,000); · Option 2: 5% of funds, up to $10,250,000, which are raised from private investors at events where Vyripharm participates in the meetings or presentation(s) will be paid; · Option 3: If less than $10,250,000 is raised in 2017, IHI will make four installment payments of $250,000 to Vyripharm, with the first at the 1 st The Company was paid the initial $250,000 down payment as required by the Agreement during the three months ending March 31, 2017. On June 30, 2017, Indoor Harvest, Alamo CBD and Vyripharm entered into discussions to amend and extend the payment terms under the Joint Venture for the 2 nd On August 7, 2017, after negotiations, the Company advised Vyripharm that it intended to voluntarily default on the Joint Venture. Indoor Harvest management determined that without a license to produce cannabis, the Company would not be able to fully utilize the intent of the Joint Venture partnership and the Company would be financially burdened by the ongoing Joint Venture terms. Both parties agreed that this decision would not impair either party’s ability to pursue a Joint Venture in the future, after Indoor Harvest, or Alamo CBD, obtained license to produce cannabis. As such, Indoor Harvest recorded a loss on investment of the joint venture as of June 30, 2017 of $250,000 as presented in the Condensed Statements of Operations. Deferred Rent Deferred rent payable at June 30, 2017 was $7,376. Deferred rent payable is the sum of the difference between the monthly rent payment and the straight-line monthly rent expense of an operating lease that contains escalated payments in future periods. Rent expense for the three and six months ended June 30, 2017 and 2016, were: Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, Rent expense $ 8,336 $ - $ 26,975 $ -

CONCENTRATIONS

CONCENTRATIONS	6 Months Ended
	Jun. 30, 2017
Risks and Uncertainties [Abstract]
CONCENTRATIONS	NOTE 5 - CONCENTRATIONS At June 30, 2017 and December 31, 2016, the Company had concentrations of accounts receivable of: Customer June 30, 2017 December 31, Tweed, Inc. - % 100 % For the three months ended June 30, 2017 and 2016, the Company had a concentration of sales of: Three Months Ended Customer June 30, June 30, University of Arizona CEAC - % 31 % GSS Colorado - % - % ER Michigan - % 55 % PH Research Platform - % 17 % UB Poland - % 69 % For the six months ended June 30, 2017 and 2016, the Company had a concentration of sales of: Six Months Ended Customer June 30, 2017 June 30, University of Arizona CEAC - % 22 % GSS Colorado - % 8 % ER Michigan - % 20 % PH Research Platform - % 6 % UB Poland - % 44 %

WORK IN PROCESS

WORK IN PROCESS	6 Months Ended
	Jun. 30, 2017
Contractors [Abstract]
WORK IN PROCESS	NOTE 6 - WORK IN PROCESS Work in progress as of June30, 2017 and December 31, 2016, consisted of the following: Description June 30, December 31, Costs incurred on uncompleted contracts $ - $ 80,620 Estimated earnings - - Less: Billings to date - (100,775 ) Total $ - $ (20,155 ) Reflected in balance sheet as: Costs and estimated earnings in excess of billings on contracts in process $ - $ - Billings in excess of costs and estimated earnings on contracts in process - 20,155 Total $ - $ 20,155

NOTE PAYABLE

NOTE PAYABLE	6 Months Ended
	Jun. 30, 2017
Notes Payable [Abstract]
NOTE PAYABLE	NOTE 7 - NOTE PAYABLE June 30, 2017 December 31, 2016 On June 5, 2015, the Company entered into a five-year loan agreement totaling $36,100. The loan carries interest at a rate of 10.25%. $ 23,824 $ 27,132 Less: current portion 7,714 6,790 Long-term note payable, net $ 16,110 $ 20,342

DEBT AND CONVERTIBLE LOAN PAYAB

DEBT AND CONVERTIBLE LOAN PAYABLE	6 Months Ended
	Jun. 30, 2017
Debt And Convertible Loan Payable [Abstract]
DEBT AND CONVERTIBLE LOAN PAYABLE	NOTE 8 - DEBT AND CONVERTIBLE LOAN PAYABLE Convertible Note Payable On March 20, 2017, the Company settled $225,500 in principal and interest, plus 115% multiplied by the principal amount of $225,500 plus accrued interest of $8,846 on the principal amount of a promissory note with Chuck Rifici Holdings, Inc originally dated September 26, 2016 (“Rifici Note”). The Company settled the amount owed by paying $269,498 in cash. The Company was released from any further liability under this Rifici Note upon payment of this amount. On March 20, 2017, the Company settled $275,000 in principal and interest, plus 115% multiplied by the principal amount of $275,000 plus accrued interest of $7,333 on the principal amount of a promissory note with FirstFire Global Opportunities Fund, LLC originally dated October 19, 2016 and December 12, 2016. The Company settled the amount owed by paying $252,917 in cash and issuing 333,333 shares of common stock with a fair value of $100,000 based upon the conversion price of $0.30 per share. The Company was released from any further liability under this FirstFire Global Opportunities Fund, LLC Note upon payment of this amount. On March 24, 2017, the Company entered into a securities purchase agreement with Tangiers Global, LLC (“Tangiers Note”), relating to the issuance and sale of notes of $550,000 in aggregate principal amount including $250,000 actual payment of purchase price plus a 10% original issue discount. The Tangiers Note carry interest on the unpaid principal amount at the rate of 8% per annum. Any principal amount or interest which is not paid when due shall bear interest at the rate of 18% per annum from the due date until the same is paid. The Tangiers Note matures on November 24, 2017 and may be prepaid in whole or in part except otherwise explicitly set forth in the Tangiers Note. If the Company exercises its right to prepay or repay the Note, the Company shall make payment to the note holders of an amount in cash equal to the following: Days Since Effective Date Prepayment Amount Under 90 days 115% of principal amount 91 - 135 days 120% of principal amount 136 - 180 days 155% of principal amount After 180 days from the effective date of this note may not be prepaid. The Tangiers Note converts into shares of common stock at a price equal to $0.30; provided, however that from and after the occurrence of any event of default hereunder, the conversion price shall be the lower of: (i) the fixed conversion price or (ii) 65% multiplied by the lowest sales price of the common stock in a public market during the fifteen (15) consecutive trading day period immediately preceding the trading day that the Company receives a Notice of Conversion (as defined in the Tangiers Note). For the six months ended June 30, 2017, the Company received $275,000 proceeds less $25,000 in original issuance discount fee pursuant to the terms of this convertible note. For convertible debt, the convertible was not in default as of June 30, 2017, as a result, the Company recorded a BCF and related debt discount. For the three and six months ended June 30, 2017, the Company accrued $5,485 and $5,907, respectively, in accrued interest related to outstanding the note. Debt Discount and Original Issuance Costs for Convertible Note During the six months ended June 30, 2017 and 2016, the Company recorded debt discounts and original issuance costs totaling $120,333 and $176,916, respectively. The debt discounts recorded in 2017 and 2016, pertain to beneficial conversion feature on the convertible notes. The notes are required to be bifurcated and reported at fair value on the date of grant. (see Note 1 Fair Value Measurements). The Company amortized $200,750 and $96,152 to interest expense during the six months ended June 30, 2017 and 2016, respectively. Six Months Year June 30, December 31, Debt discount, beginning of period $ 152,617 $ - Additional debt discount and debt issue cost 120,333 417,834 Amortization of debt discount and debt issue cost (200,750 ) (265,217 ) Debt discount, end of period $ 72,200 $ 152,617 Debt Issuance Costs for Convertible Note During the six months ended June 30, 2017 and 2016, the Company paid debt issuance costs totaling $0 and $10,000, respectively. During the six months ended June 30, 2017 and 2016, the Company amortized $7,473 and $0 of debt issue costs, respectively. Six Months Year Ended June 30, December 31, Debt discount, beginning of period $ 7,473 $ - Additional debt discount 10,000 Amortization of debt discount (7,473 ) (2,527 ) Debt discount, end of period $ - $ 7,473 Debt Discount for Promissory Note During the six months ended June 30, 2017 and 2016, the Company recorded debt discount of $0 and $0, respectively. The Company amortized $15,715 and $0 to interest expense during the six months ended June 30, 2017 and 2016, respectively.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 - RELATED PARTY TRANSACTIONS January 16, 2017, the Company issued 145,740 shares of common stock related to a Director Agreement with Pawel Hardej. The Company recorded fair value of $64,126 ($0.44/share) based upon the most recent trading price per share of the Company's stock. January 16, 2017, the Company issued 41,640 shares of common stock related to a Director Agreement with John Zimmerman. The Company recorded fair value of $18,322 ($0.44/share) based upon the most recent trading price per share of the Company's stock. January 16, 2017, the Company issued 62,460 shares of common stock related to a Director Agreement with John Choo. The Company recorded fair value of $27,482 ($0.44/share) based upon the most recent trading price per share of the Company's stock.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	6 Months Ended
	Jun. 30, 2017
Equity [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 10 - STOCKHOLDERS' DEFICIT Series A Convertible Preferred Stock During the third quarter 2016, the Company initiated a subscription agreement to offer accredited investors up to 1,000,000 units (“Unit”) of security, where each Unit consists of one (1) share of Series A Convertible Preferred Stock and one (1) Series A Warrant. The price per Unit is $0.50 for a maximum aggregate of 1,000,000 Units and maximum aggregate proceeds of $500,000. The stated value of each preferred stock is $0.50 and there are no dividends on the Series A Convertible Preferred Stock. The Warrants are exercisable at $0.50 per share and shall be exercisable for a period of one year. From August 15 to August 29, 2016, the Company subscribed 250,000 Units to three (3) investors for total proceeds of $125,000. During the six months ended June 30, 2017 and 2016, the Company amortized $33,238 and $0 of debt discount related to the warrants, respectively. The remaining debt discount related to the warrants is $0. On March 20, 2017, the Company's Series A Preferred Convertible Stock shareholders ("Series A Holders") each voted to waive and remove the provisions of Section 5(iii) of the Series A Preferred Stock Designation. This waives and removes what is known as “full ratchet protection” provisions for adjustments in the Conversion Price and formula. Series A Holders have each agreed individually and also as a group to convert their Series A Convertible Preferred Stock into common stock at a conversion price equal to $0.30 per share. A total of 250,000 shares of the Company's Series A Preferred Convertible Stock were converted into 416,667 shares of common stock. From April 26, 2017 through May 3, 2017, the Company sold 750,000 shares of Series A Preferred Common Stock to thirteen (13) U.S. accredited investors at $0.40 per share for cash totaling $300,000. Common Stock January 16, 2017, the Company issued 145,740 shares of common stock related to a Director Agreement with Pawel Hardej. The Company recorded fair value of $64,126 ($0.44/share) based upon the most recent trading price per share of the Company's stock. January 16, 2017, the Company issued 41,640 shares of common stock related to a Director Agreement with John Zimmerman. The Company recorded fair value of $18,322 ($0.44/share) based upon the most recent trading price per share of the Company's stock. January 16, 2017, the Company issued 62,460 shares of common stock related to a Director Agreement with John Choo. The Company recorded fair value of $27,482 ($0.44/share) based upon the most recent trading price per share of the Company's stock. January 17, 2017, the Company issued 800,000 shares of common stock to Lyons Capital, LLC for a six-month consulting and road show services agreement. The Company recorded fair value of $352,000 ($0.44/share) based upon the most recent trading price per share of the Company's stock. From February 22, 2017 through March 15, 2017, the Company sold, in reliance upon Regulation D Rule 506, a total of 2,060,000 shares of common stock to seventeen (17) U.S. accredited investors at $0.40 per share for cash totaling $824,000. On March 20, 2017, the Company settled the amount owed to FirstFire Global Opportunities Fund LLC by paying $252,917 in cash and issuing 333,333 shares of common stock with a fair value of $100,000 based upon the conversion price of $0.30/share (See Note 8). On March 20, 2017, a total of 250,000 shares of the Company's Series A Preferred Convertible Stock were converted into 416,667 shares of Common Stock. The Company recorded fair value of $175,000 ($0.42/share) based upon the most recent trading price per share of the Company’s stock. On June 1, 2017, the Company issued 250,000 shares of common stock for a 12-month investor relations consulting agreement. The Company recorded fair value of $55,000 ($0.22/share) based upon the most recent trading price per share of the Company's stock. Common Stock Warrants On September 26, 2016, the Company entered a promissory note with Chuck Rifici Holdings, Inc. (“Rifici Note”), relating to the issuance of $225,500 in aggregate principal including a $204,000 actual payment of purchase price plus a 10% original issue discount. In conjunction with the issuance of the Rifici Note, the Company issued a one-year warrant to purchase 250,000 shares of common stock at an exercise price of $0.30 per share (See Note 8). Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2016 500,000 - - Granted - - - Exercised - - - Canceled/Forfeited 250,000 - - Balance June 30, 2017 250,000 $ 0.30 $ 0.24 For the six months ended June 30, 2017, the following warrants were outstanding: Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.30 250,000 0.24 - For the year ended December 31, 2016, the following warrants were outstanding: Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate $ 0.30-0.50 500,000 0.69 32,500 Lattice Binomial model was used to value aggregate intrinsic value.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11 - SUBSEQUENT EVENTS On August 3, 2017, the Company formed Alamo Acquisition, LLC, a Texas limited liability Company, in which Indoor Harvest Corp owns 100% of Alamo Acquisition, LLC member interests. On August 4, 2017, the Company entered into an Agreement and Plan of Merger and Reorganization, by and among Indoor Harvest Corp, a Texas corporation, Alamo Acquisition LLC., a Texas Limited Liability Company, and Alamo CBD, LLC, a Texas Limited Liability Company. On August 9, 2017, Chad Sykes, the Company’s founder and largest shareholder canceled and returned to the unissued and authorized shares of the Company, 2,500,000 shares of the Company common stock. Because of the cancellation of shares, the Company currently has 16,823,352 shares of common stock outstanding. On August 9, 2016, Mr. John Choo resigned as a Director and Chief Executive Officer in the Company. Mr. Choo's resignation was not the result of any disagreement with us on any matter relating to our operations, policies (including accounting or financial policies) or practices. A majority of the Board of Directors decided to restructure the Board of Directors to better reflect the Company's current business direction and Mr. Choo voluntarily agreed to resign as part of that restructuring effort. On August 9, 2017, Rick Gutshall was elected as a Director, Interim Chief Executive Officer and Chief Financial Officer of the Corporation. On August 9, 2016, Mr. Pawel Hardej resigned as a Director in the Company. Mr. Hardej’s resignation was not the result of any disagreement with us on any matter relating to our operations, policies (including accounting or financial policies) or practices. A majority of the Board of Directors decided to restructure the Board of Directors to better reflect the Company's current business direction and Mr. Hardej voluntarily agreed to resign as part of that restructuring effort. On August 9, 2017, Annette Knebel was elected as a Director and Chief Accounting Officer of the Corporation. On August 9, 2016, Mr. Chad Sykes resigned as a Director and Chief Innovation Officer in the Company. Mr. Sykes’ resignation was not the result of any disagreement with us on any matter relating to our operations, policies (including accounting or financial policies) or practices. A majority of the Board of Directors decided to restructure the Board of Directors to better reflect the Company's current business direction and Mr. Sykes voluntarily agreed to resign as part of that restructuring effort. On August 9, 2017, Dr. Lang Coleman was elected as a Director of the Corporation. On August 9, 2017, John Seckman was elected as a Director and Interim-Chairman of the Corporation.

SUMMARY OF SIGNIFICANT ACCOUN18

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (GAAP). It is management's opinion, however, that all material adjustments (consisting of normal and recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. Indoor Harvest Corp., or the "Company," is a Texas corporation formed on November 23, 2011. Indoor Harvest Corp., through its brand name Indoor Harvest™, is a company specializing in equipment design, development, marketing and direct-selling of commercial grade aeroponics fixtures and supporting systems for use in urban Controlled Environment Agriculture ("CEA") and Building Integrated Agriculture ("BIA"). Indoor Harvest Corp transitioned in the first half of 2017 from an Engineering, Procurement and Construction Management Company for the vertical farming industry, into a developer of personalized cannabis medicines, and a provider of advanced cultivation technology, methods and processes for cannabis production. These unaudited interim condensed financial statements should be read in conjunction with the financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2016, filed with the SEC on April 17, 2017.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited to the estimate of percentage of completion on construction contracts in progress at each reporting period which we rely on as a primary basis of revenue recognition, estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid instruments with a maturity of three months or less to be cash and cash equivalents.
Accounts Receivable and Work in Progress	Accounts Receivable and Work in Progress Work in process consists of costs recorded and revenue earned on projects recognized on the percentage of completion method for work performed on contracts in progress at June 30, 2017 and December 31, 2016. The Company records revenue based on contractual agreements entered into at the inception of construction contracts. Amounts are payable from customers based on milestones established in each contract. Amounts are billed at milestone completion and are reflected as accounts receivable when billed. Costs and estimated earnings are accumulated on projects in process and compared to amounts billed based on the percentage of completion method of accounting (cost to cost). Costs incurred in excess of amounts billed and related profit recognized are reflected as an asset in the balance sheet as costs and estimated earnings in excess of billings. Unearned billings are reflected in the balance sheet as a liability as billings in excess of costs and estimated earnings on projects in process (See Note 6).
Inventories	Inventories Inventory consists primarily of raw materials and packaging materials and is valued at the lower of cost or market. Cost is determined using the weighted average method and average cost is recomputed after each inventory purchase or sale. Inventory is periodically reviewed to identify obsolete or damaged inventory and impaired values. Inventory is comprised of raw materials such as steel for our framing systems and packaging materials such as boxes and pallets valued at $2,360 at both June 30, 2017 and December 31, 2016.
Revenue Recognition	Revenue Recognition The Company recognizes revenue on arrangements in accordance with ASC No. 605, Revenue Recognition. In all cases, revenue is recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. The Company will generate revenue from the design and installation of the equipment. Revenue from construction contracts are reported under the percentage of completion method for financial statement purposes. The estimated revenue for each contract reflected in the financial statements represent that percentage of estimated total revenue that costs incurred to date bear to estimated total costs, based on the Company’s current estimates. With respect to contracts that extend over one or more accounting periods, revisions in costs and revenue estimates during the work are reflected in the period the revisions become known. When current estimates of total contract costs indicate a loss, provision is made for the entire estimated loss. The asset, “costs and estimated earnings in excess of billings on uncompleted contracts,” represents revenues recognized in excess of amounts billed. The liability, “Estimated earnings on uncompleted contracts,” represents billings in excess of revenues recognized. Billing practices for these projects are governed by the contract terms of each project based upon actual costs incurred, achievement of milestones, or pre-agreed schedules. Billings do not necessarily correlate with revenue recognized under the percentage of completion method of accounting. Except for claims and change orders that are in the process of being negotiated with customers, unbilled work is usually billed during normal billing processes following achievement of the contractual requirements.
Stock Based Compensation	Stock Based Compensation The Company recognizes stock based compensation in accordance with ASC 718-10, Stock Compensation. ASC 718-10 focuses on transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus in which an entity obtains employee services in stock based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award (with limited exceptions).
Basic Loss per Share	Basic Loss per Share Basic loss per share amounts are calculated based on the weighted average number of shares of common stock outstanding during each period. Diluted earnings per share is based on the weighted average numbers of shares of common stock outstanding for the periods, including dilutive effects of stock options, warrants granted and convertible preferred stock. Dilutive options and warrants that are issued during a period or that expire or are canceled during a period are reflected in the computations for the time they were outstanding during the periods being reported. Since the Company has incurred losses for all periods, the impact of the common stock equivalents would be antidilutive and therefore are not included in the calculation. The Company has the following common stock equivalents for the six months ended June 30, 2017 and 2016, respectively: June 30, June 30, Convertible debt (exercise price - $0.30/share) 916,667 908,333
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company adopted ASC 820 Fair Value Measurements for financial and non-financial assets and liabilities. The adoption did not have a material impact on our results of operations, financial position or liquidity. This standard defines fair value and provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share based payments. ASC 820 discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: · Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. · Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. · Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. Carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to their relatively short maturity. Debt classified as Level 2 in the fair value hierarchy represent note payable, net of debt discount, of $0 and $209,786 at June 30, 2017 and December 31, 2016, respectively, and convertible notes payable of $202,800 and $122,383 at June 30, 2017 and December 31, 2016, respectively.
Income Taxes	Income Taxes The Company accounts for income taxes pursuant to ASC 740 “Income Taxes,” which requires recognition of deferred income tax liabilities and assets for the expected future tax consequences of events that have been recognized in the financial statements or tax returns. The Company provides for deferred taxes on temporary differences between the financial statements and tax basis of assets using the enacted tax rates that are expected to apply to taxable income when the temporary differences are expected to reverse. ASC 740 establishes a more likely than not threshold for recognizing the benefits of tax return positions in the financial statements. Also, the statement implements a process for measuring those tax positions that meet the recognition threshold of being ultimately sustained upon examination by the taxing authorities. There are no uncertain tax positions taken by the Company on its tax returns. The Company files tax returns in the U.S. and states in which it has operations and is subject to taxation. Tax years 2016, 2015, 2014, 2013, 2012 and 2011, remain subject to examination by the IRS and respective states.
Property and Equipment	Property and Equipment Property and equipment is recorded at cost and depreciated or amortized using the straight-line method over the estimated useful life of the asset or the underlying lease term for leasehold improvements, whichever is shorter. The estimated useful life by asset description is noted in the following table: Asset Description Estimated Useful Life (Years) Furniture and equipment 3 - 5 Tooling equipment 10 Leasehold improvements * __________ * The shorter of 5 years or the life of the lease. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in other income.
Intangible Assets	Intangible Assets The Company's intangible assets consist of the domain name and is accounted for as an indefinite lived intangible asset in accordance with ASC 350 "Goodwill and Other Intangible Assets" ("ASC 350"). It also includes software and is amortized over a 3-5-year period. Intangible assets are reviewed annually for impairment or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no impairment charges taken during the six months ended June 30, 2017 and 2016. Intangible assets consist of the following at June 30, 2017 and December 31, 2016: Classification June 30, December 31, Domain name $ 2,000 $ 2,000 Facilities Manager's Package Online 1,022 1,022 MLC CD Systems (software) 7,560 7,560 Total 10,582 10,582 Less: Accumulated amortization (3,832 ) (2,978 ) Intangible assets, net $ 6,750 $ 7,604
Patent and Patent Application Expenses	Patent and Patent Application Expenses Although the Company believes that its patent and underlying technology will have continuing value, the amount of future benefits to be derived from the patent is uncertain. Therefore, patent costs are expensed as incurred.
Research and Development	Research and Development Research and development expenditures are charged to expense as incurred. Research and development expense for the three and six months ended June 30, 2017 and 2016 are as follows: Three Months Ended Six Months Ended June 30, June 30, 2016 June 30, June 30, 2016 Research and development expense $ 887 $ 5,641 $ 1,625 $ 8,672
Advertising Expense	Advertising Expense Advertising and promotional costs are expensed as incurred. Advertising expense for the three and six months ended June 30, 2017 and 2016, are as follows: Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, Advertising expense $ 3,036 $ - $ 12,887 $ -
Reclassifications	Reclassifications Certain balance sheet items have been reclassified at December 31, 2016 to conform to the reporting format adopted at June 30, 2017.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect as of the date of the issuance of these financial statements. The following pronouncements may impact future reporting of financial position and results of operations. Management is currently assessing implementation. The FASB issued Accounting Standards Update (ASU) No. 2017-01, Business Combinations (Topic 805) clarifying the definition of a business. The amendment affects all companies and other reporting organizations that must determine whether they have acquired or sold a business. For public companies, the amendment is effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) providing new lease accounting guidance. Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: · A lease liability, which is a lessee‘s obligation to make lease payments arising from a lease, measured on a discounted basis; and · A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. · Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic 606, Revenue from Contracts with Customers. · The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. Public business entities should apply the amendments in ASU 2016-02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (i.e., January 1, 2019, for a calendar year entity). The FASB has issued Accounting Standards Update (ASU) No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments are intended to improve the accounting for employee share-based payments and affect all organizations that issue share-based payment awards to their employees. Several aspects of the accounting for share-based payment award transactions are simplified, including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. For public companies, the amendments are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For private companies, the amendments are effective for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. Early adoption is permitted for any organization in any interim or annual period. The FASB issued Accounting Standards Update No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. The amendment clarifies the following two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The amendment does not change the core principle of the guidance in Topic 606. The effective date and transition requirements for the amendment is the same as the effective date and transition requirements in Topic 606. Public entities should apply the amendments for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein (i.e., January 1, 2018, for a calendar year entity). Early application for public entities is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The effective date for nonpublic entities is deferred by one year.
Derivative Liability	Derivative Liability The Company accounts for derivative instruments in accordance with ASC 815 Derivatives and Hedging, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At June 30, 2017 and December 31, 2016, the Company did not have any derivative instruments that were designated as hedges.
Beneficial Conversion Feature	Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a "beneficial conversion feature" ("BCF") and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The discount is amortized to interest expense over the life of the debt.

SUMMARY OF SIGNIFICANT ACCOUN19

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Schedule of common stock equivalents	June 30, June 30, Convertible debt (exercise price - $0.30/share) 916,667 908,333
Schedule of estimated useful life by asset description	Asset Description Estimated Useful Life (Years) Furniture and equipment 3 - 5 Tooling equipment 10 Leasehold improvements * __________ * The shorter of 5 years or the life of the lease.
Schedule of intangible asset	Classification June 30, December 31, Domain name $ 2,000 $ 2,000 Facilities Manager's Package Online 1,022 1,022 MLC CD Systems (software) 7,560 7,560 Total 10,582 10,582 Less: Accumulated amortization (3,832 ) (2,978 ) Intangible assets, net $ 6,750 $ 7,604
Schedule of research and development expense	Three Months Ended Six Months Ended June 30, June 30, 2016 June 30, June 30, 2016 Research and development expense $ 887 $ 5,641 $ 1,625 $ 8,672
Schedule of advertising expense	Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, Advertising expense $ 3,036 $ - $ 12,887 $ -

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	6 Months Ended
	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Classification June 30, December 31, Furniture and equipment $ 124,379 $ 123,827 Tooling equipment 27,015 27,015 Leasehold improvements 57,780 57,780 Computer equipment 6,169 6,169 Research and development lab 63,177 63,177 Total 278,520 277,968 Less: Accumulated depreciation (144,952 ) (119,550 ) Property and equipment, net $ 133,568 $ 158,418

COMMITMENTS & CONTINGENCIES (Ta

COMMITMENTS & CONTINGENCIES (Tables)	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Schedule of rent expense	Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, Rent expense $ 8,336 $ - $ 26,975 $ -

CONCENTRATIONS (Tables)

CONCENTRATIONS (Tables)	6 Months Ended
	Jun. 30, 2017
Risks and Uncertainties [Abstract]
Schedule of concentration of accounts receivable and sales	Customer June 30, 2017 December 31, Tweed, Inc. - % 100 % Three Months Ended Customer June 30, June 30, University of Arizona CEAC - % 31 % GSS Colorado - % - % ER Michigan - % 55 % PH Research Platform - % 17 % UB Poland - % 69 % Six Months Ended Customer June 30, 2017 June 30, University of Arizona CEAC - % 22 % GSS Colorado - % 8 % ER Michigan - % 20 % PH Research Platform - % 6 % UB Poland - % 44 %

WORK IN PROCESS (Tables)

WORK IN PROCESS (Tables)	6 Months Ended
	Jun. 30, 2017
Contractors [Abstract]
Schedule of Work in progress	Description June 30, December 31, Costs incurred on uncompleted contracts $ - $ 80,620 Estimated earnings - - Less: Billings to date - (100,775 ) Total $ - $ (20,155 ) Reflected in balance sheet as: Costs and estimated earnings in excess of billings on contracts in process $ - $ - Billings in excess of costs and estimated earnings on contracts in process - 20,155 Total $ - $ 20,155

NOTE PAYABLE (Tables)

NOTE PAYABLE (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Payable [Abstract]
Schedule of Notes payable	June 30, 2017 December 31, 2016 On June 5, 2015, the Company entered into a five-year loan agreement totaling $36,100. The loan carries interest at a rate of 10.25%. $ 23,824 $ 27,132 Less: current portion 7,714 6,790 Long-term note payable, net $ 16,110 $ 20,342

DEBT AND CONVERTIBLE LOAN PAY25

DEBT AND CONVERTIBLE LOAN PAYABLE (Tables)	6 Months Ended
	Jun. 30, 2017
Debt And Convertible Loan Payable [Abstract]
Schedule of convertible note payable	Days Since Effective Date Prepayment Amount Under 90 days 115% of principal amount 91 - 135 days 120% of principal amount 136 - 180 days 155% of principal amount
Schedule of debt discount and original issuance costs	Six Months Year June 30, December 31, Debt discount, beginning of period $ 152,617 $ - Additional debt discount and debt issue cost 120,333 417,834 Amortization of debt discount and debt issue cost (200,750 ) (265,217 ) Debt discount, end of period $ 72,200 $ 152,617
Schedule of debt issuance costs	Six Months Year Ended June 30, December 31, Debt discount, beginning of period $ 7,473 $ - Additional debt discount 10,000 Amortization of debt discount (7,473 ) (2,527 ) Debt discount, end of period $ - $ 7,473

STOCKHOLDERS' DEFICIT (Tables)

STOCKHOLDERS' DEFICIT (Tables)	6 Months Ended
	Jun. 30, 2017
Equity [Abstract]
Schedule of warrant activity during the year	Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2016 500,000 - - Granted - - - Exercised - - - Canceled/Forfeited 250,000 - - Balance June 30, 2017 250,000 $ 0.30 $ 0.24
Schedule of outstanding warrants	Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.30 250,000 0.24 - Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate $ 0.30-0.50 500,000 0.69 32,500

SUMMARY OF SIGNIFICANT ACCOUN27

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - shares	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Convertible Debt (Exercise price - $0.30/share)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	916,667	908,333

SUMMARY OF SIGNIFICANT ACCOUN28

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Parentheticals) (Details)	6 Months Ended
	Jun. 30, 2017USD ($)
Convertible Debt (Exercise price - $0.30/share)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from Computation of earnings per share, exercise price (in dollars per share)	$ 0.30

SUMMARY OF SIGNIFICANT ACCOUN29

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	6 Months Ended
	Jun. 30, 2017
Furniture and equipment
Accounting Policies [Line Items]
Estimate Useful Life (Years)	3 - 5 Years
Tooling equipment
Accounting Policies [Line Items]
Estimate Useful Life (Years)	10 Years
Leasehold improvements
Accounting Policies [Line Items]
Estimate Useful Life (Years)	The shorter of 5 years or the life of the lease.

SUMMARY OF SIGNIFICANT ACCOUN30

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Accounting Policies [Line Items]
Intangible assets, gross	$ 10,582	$ 10,582
Less: Accumulated amortization	(3,832)	(2,978)
Intangible asset, net	6,750	7,604
Domain Name
Accounting Policies [Line Items]
Indefinite-lived intangible assets	2,000	2,000
Facilities Manager's Package Online
Accounting Policies [Line Items]
Finite-lived intangible assets, gross	1,022	1,022
MLC CD Systems (software)
Accounting Policies [Line Items]
Finite-lived intangible assets, gross	$ 7,560	$ 7,560

SUMMARY OF SIGNIFICANT ACCOUN31

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Accounting Policies [Abstract]
Research and development expense	$ 887	$ 5,641	$ 1,625	$ 8,672

SUMMARY OF SIGNIFICANT ACCOUN32

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Accounting Policies [Abstract]
Advertising expense	$ 3,036		$ 12,887

SUMMARY OF SIGNIFICANT ACCOUN33

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) - USD ($)	6 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Accounting Policies [Line Items]
Inventory of raw materials for framing systems and packaging materials	$ 2,360	$ 2,360
Note payable, net of discount		209,786
Convertible note payable, net of debt discount	$ 202,800	$ 122,383
Software | Maximum
Accounting Policies [Line Items]
Amortization period	5 years
Software | Minimum
Accounting Policies [Line Items]
Amortization period	3 years

GOING CONCERN (Detail Textuals)

GOING CONCERN (Detail Textuals) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Going Concern [Abstract]
Net loss	$ (724,385)	$ (515,846)	$ (1,780,636)	$ (837,536)
Net cash used in operations			(988,218)	$ (338,575)
Accumulated deficit	$ (5,777,408)		$ (5,777,408)		$ (3,996,772)

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Total	$ 278,520	$ 277,968
Less: Accumulated Depreciation and Amortization	(144,952)	(119,550)
Property & Equipment, net	133,568	158,418
Furniture and equipment
Property, Plant and Equipment [Line Items]
Total	124,379	123,827
Tooling equipment
Property, Plant and Equipment [Line Items]
Total	27,015	27,015
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total	57,780	57,780
Computer equipment
Property, Plant and Equipment [Line Items]
Total	6,169	6,169
Research and development lab
Property, Plant and Equipment [Line Items]
Total	$ 63,177	$ 63,177

PROPERTY AND EQUIPMENT (Detail

PROPERTY AND EQUIPMENT (Detail Textuals)	6 Months Ended
	Jun. 30, 2017USD ($)
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 25,402

COMMITMENTS & CONTINGENCIES (De

COMMITMENTS & CONTINGENCIES (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 8,336		$ 26,975

COMMITMENTS & CONTINGENCIES (38

COMMITMENTS & CONTINGENCIES (Detail Textuals) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 23, 2017	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2017	Feb. 15, 2017	Dec. 31, 2016
Commitments And Contingencies [Line Items]
Deferred rent payable		$ 7,376		$ 7,376		$ 8,513
Loss on investment in joint venture		$ 250,000		$ 250,000
Binding letter of intent | Alamo CBD, LLC ("Alamo CBD")
Commitments And Contingencies [Line Items]
Maximum capital required to pay off existing debt					$ 1,000,000
Contractual Joint Venture Agreement | Vyripharm Enterprises, LLC ("Vyripharm") and Alamo CBD
Commitments And Contingencies [Line Items]
Total contribution in joint venture	$ 5,000,000
Per year contribution in joint venture	1,000,000
Payment made in first anniversary of joint venture	1,000,000
Payment made in second anniversary of joint venture	1,000,000
Payment made in third anniversary of joint venture	1,000,000
Payment made in fourth anniversary of joint venture	1,000,000
Payment made in fifth anniversary of joint venture	$ 1,000,000
Description of conditions for fail in payments	if IHI failed to timely pay the initial $1,000,000, the JV Agreement would terminate and neither Party would have further obligation to the other. If IHI failed to pay the second $1,000,000 payment within thirty (30) days following the second anniversary of the Effective Date, then the JV Agreement would terminate and Alamo CBD would forfeit four-fifths (4/5) of its revenue share from any product that had been developed or would be subsequently developed by Vyripharm using the cannabis oil and/or processes supplied to Vyripharm by IHI. If IHI failed to pay the third $1,000,000 payment within thirty (30) days following the third anniversary of the Effective Date, then the JV Agreement would terminate and IHI would forfeit three-fifths (3/5) of its revenue share from any product that had been developed or would subsequently be developed by Vyripharm using the medical cannabis oil and/or processes supplied to Vyripharm by IHI. If IHI fails to pay the fourth $1,000,000 payment within thirty (30) days following the fourth anniversary of the Effective Date, then the JV Agreement would terminate and IHI would forfeit four-fifths (2/5) of its revenue share from any product that had been developed or would be subsequently developed by Vyripharm using the medical cannabis oil and/or processes supplied to Vyripharm by IHI. If IHI fails to pay the fifth $1,000,000 payment within thirty (30) days following the fifth anniversary of the Effective Date, then the JV Agreement would terminate and IHI would forfeit one-fifth (1/5) of its revenue share from any product that had been developed or was subsequently developed by Vyripharm using the medical cannabis oil and/or processes supplied to Vyripharm by IHI. Except for cost sharing for the filing of, prosecuting and maintaining any joint patent applications pursuant to Paragraph 6 of this Agreement, and unless the Parties mutually agree, IHI will have no further financial obligations under the JV Agreement during the Initial Term, and the Parties must bear their own costs in carrying out their respective responsibilities under this Agreement.
Description of conditions for pay out structure	Based on the described fees and schedule that Vyripharm must attain with the institutions in the TMC, the Company can only accept a payout structure of the first $1,000,000 under the following three scenarios: · Option 1: All $1,000,000 for the year will be paid to Vyripharm in advance if excess funds are raised (above $10,250,000); · Option 2: 5% of funds, up to $10,250,000, which are raised from private investors at events where Vyripharm participates in the meetings or presentation(s) will be paid; · Option 3: If less than $10,250,000 is raised in 2017, IHI will make four installment payments of $250,000 to Vyripharm, with the first at the 1 st
Down payment under joint venture agreement			$ 250,000
Initial term of the Joint Venture	5 years

CONCENTRATIONS (Details)

CONCENTRATIONS (Details)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Accounts receivable | Tweed, Inc.
Concentration Risk [Line Items]
Percentage of concentration					100.00%
Sales revenue | University of Arizona CEAC
Concentration Risk [Line Items]
Percentage of concentration		31.00%		22.00%
Sales revenue | GSS Colorado
Concentration Risk [Line Items]
Percentage of concentration				8.00%
Sales revenue | ER Michigan
Concentration Risk [Line Items]
Percentage of concentration		55.00%		20.00%
Sales revenue | PH Research Platform
Concentration Risk [Line Items]
Percentage of concentration		17.00%		6.00%
Sales revenue | UB Poland
Concentration Risk [Line Items]
Percentage of concentration		69.00%		44.00%

WORK IN PROCESS (Details)

WORK IN PROCESS (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Contractors [Abstract]
Costs incurred on uncompleted contracts		$ 80,620
Estimated earnings
Less: Billings to date		(100,775)
Total		(20,155)
Reflected in balance sheet as:
Costs and estimated earnings in excess of billings on contracts in process
Billings in excess of costs and estimated earnings on contracts in process		20,155
Total		$ 20,155

NOTE PAYABLE (Details)

NOTE PAYABLE (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Notes Payable [Abstract]
On June 5, 2015, the Company entered into a five-year loan agreement totaling $36,100. The loan carries interest at a rate of 10.25%	$ 23,824	$ 27,132
Less: current portion	7,714	6,790
Long-term note payable, net	$ 16,110	$ 20,342

NOTE PAYABLE (Detail Textuals)

NOTE PAYABLE (Detail Textuals)	Jun. 05, 2015USD ($)
Notes Payable [Abstract]
Loan payable term	5 years
Principal loan amount	$ 36,100
Loan payable, interest rate	10.25%

DEBT AND CONVERTIBLE LOAN PAY43

DEBT AND CONVERTIBLE LOAN PAYABLE (Details) - Convertible note payable	6 Months Ended
	Jun. 30, 2017
Under 90 days
Debt And Convertible Loan Payable [Line Items]
Days Since Effective Date	Under 90 days
Prepayment Amount	115% of principal amount
91 - 135 days
Debt And Convertible Loan Payable [Line Items]
Days Since Effective Date	91 - 135 days
Prepayment Amount	120% of principal amount
136 - 180 days
Debt And Convertible Loan Payable [Line Items]
Days Since Effective Date	136 - 180 days
Prepayment Amount	155% of principal amount

DEBT AND CONVERTIBLE LOAN PAY44

DEBT AND CONVERTIBLE LOAN PAYABLE (Details 1) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Debt Instrument, Unamortized Discount [Roll Forward]
Debt discount, beginning of period	$ 152,617
Additional debt discount and debt issue cost	120,333	417,834
Amortization of debt discount and debt issue cost	(200,750)	(265,217)
Debt discount, end of period	$ 72,200	$ 152,617

DEBT AND CONVERTIBLE LOAN PAY45

DEBT AND CONVERTIBLE LOAN PAYABLE (Details 2) - USD ($)	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Debt Instrument, Unamortized Debt Issue Costs [Roll Forward]
Debt discount, beginning of period		$ 7,473
Additional debt discount				10,000
Amortization of debt discount	$ 44,695	249,702	$ 83,922	(2,527)
Debt discount, end of period				$ 7,473

DEBT AND CONVERTIBLE LOAN PAY46

DEBT AND CONVERTIBLE LOAN PAYABLE (Detail Textuals) - USD ($)	1 Months Ended			3 Months Ended	6 Months Ended		12 Months Ended
	Mar. 24, 2017	Mar. 20, 2017	Sep. 26, 2016	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016	Mar. 31, 2017
Debt And Convertible Loan Payable [Line Items]
Proceeds from convertible note payable						$ 230,000
Repayments of note payable					$ 228,807	2,987
Value of common stock issued for services					516,930
Additional debt discount							$ 10,000
Interest expense				$ 5,485	5,907
Debt Discount and Original Issuance Costs for Convertible Note
Debt And Convertible Loan Payable [Line Items]
Additional debt discount					120,333	176,916
Interest expense					200,750	96,152
Debt Issuance Costs for Convertible Note
Debt And Convertible Loan Payable [Line Items]
Additional debt discount					0	10,000
Amortization of debt issue costs					7,473	0
Debt Discount for Promissory Note
Debt And Convertible Loan Payable [Line Items]
Additional debt discount					0	0
Interest expense					$ 15,715	$ 0
Chuck Rifici Holdings, Inc
Debt And Convertible Loan Payable [Line Items]
Proceeds from notes payable			$ 225,500
Repayments of note payable		$ 225,500	$ 204,000
Original issue discount percentage			10.00%
Number of common stock called by warrants			250,000
Exercise price of warrant			$ 0.30
Principle and interest amount settled		$ 269,498
Percentage multiplied by principal and accrued interest		115.00%
Principal amount		$ 225,500
Accrued interest		8,846
Securities purchase agreement | Firstfire Global Opportunities Fund, LLC
Debt And Convertible Loan Payable [Line Items]
Repayments of note payable		252,917
Value of common stock issued for services		$ 100,000
Conversion of debt, shares issued		333,333
Principle and interest amount settled		$ 275,000
Percentage multiplied by principal and accrued interest		115.00%
Principal amount		$ 275,000
Accrued interest		$ 7,333
Conversion of stock price per share		$ 0.30
Securities purchase agreement | Tangiers Global, LLC
Debt And Convertible Loan Payable [Line Items]
Proceeds from notes payable	$ 550,000
Proceeds from convertible note payable	275,000
Repayments of note payable	$ 250,000
Original issue discount percentage	10.00%
Interest rate percentage on unpaid principal amount	8.00%
Debt default percentage	18.00%
Debt default description	If the Company exercises its right to prepay or repay the Note, the Company shall make payment to the note holders of an amount in cash equal to the following: After 180 days from the effective date of this note may not be prepaid.The Tangiers Note converts into shares of common stock at a price equal to $0.30; provided, however that from and after the occurrence of any event of default hereunder, the conversion price shall be the lower of: (i) the fixed conversion price or (ii) 65% multiplied by the lowest sales price of the common stock in a public market during the fifteen (15) consecutive trading day period immediately preceding the trading day that the Company receives a Notice of Conversion (as defined in the Tangiers Note). For the six months ended June 30, 2017, the Company received $275,000 proceeds less $25,000 in original issuance discount fee pursuant to the terms of this convertible note. For convertible debt, the convertible was not in default as of June 30, 2017, as a result, the Company recorded a BCF and related debt discount.
Original issuance discount fee								$ 25,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Detail Textuals) - USD ($)	1 Months Ended	6 Months Ended
	Jan. 16, 2017	Jun. 30, 2017
Related Party Transaction [Line Items]
Shares of common stock with a fair value		$ 516,930
Director Agreement | Pawel Hardej
Related Party Transaction [Line Items]
Common stock issued for services (in shares)	145,740
Shares of common stock with a fair value	$ 64,126
Shares issued price per share (in dollars per share)	$ 0.44
Director Agreement | John Zimmerman
Related Party Transaction [Line Items]
Common stock issued for services (in shares)	41,640
Shares of common stock with a fair value	$ 18,322
Shares issued price per share (in dollars per share)	$ 0.44
Director Agreement | John Choo
Related Party Transaction [Line Items]
Common stock issued for services (in shares)	62,460
Shares of common stock with a fair value	$ 27,482
Shares issued price per share (in dollars per share)	$ 0.44

SHAREHOLDERS' EQUITY (Details)

SHAREHOLDERS' EQUITY (Details) - Warrant	6 Months Ended
	Jun. 30, 2017$ / sharesshares
Number of Warrants
Balance, December 31, 2016	500,000
Granted
Exercised
Cancelled/Forfeited	250,000
Balance June 30, 2017	250,000
Weighted Average Exercise Price
Balance, December 31, 2016 | $ / shares
Balance June 30, 2017 | $ / shares	$ 0.30
Weighted Average Remaining Contractual Life (in Years)
Balance June 30, 2017	2 months 27 days

SHAREHOLDERS' EQUITY (Details 1

SHAREHOLDERS' EQUITY (Details 1) - Warrant - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Class of Warrant or Right [Line Items]
Exercise Price Warrants Outstanding	$ 0.30
Warrants Exercisable	250,000	500,000
Weighted Average Remaining Contractual Life	2 months 27 days	8 months 9 days
Aggregate Intrinsic Value		$ 32,500
Minimum
Class of Warrant or Right [Line Items]
Exercise Price Warrants Outstanding		$ 0.30
Maximum
Class of Warrant or Right [Line Items]
Exercise Price Warrants Outstanding		$ 0.50

SHAREHOLDERS' EQUITY (Detail Te

SHAREHOLDERS' EQUITY (Detail Textuals)	May 03, 2017USD ($)Investor$ / shares	Aug. 29, 2016USD ($)Investorshares	Jun. 30, 2017USD ($)$ / sharesshares	Sep. 30, 2016USD ($)$ / shares$ / unitshares	Jun. 30, 2017USD ($)$ / sharesshares	Jun. 30, 2016USD ($)	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)
Class of Stock [Line Items]
Preferred stock, shares authorized | shares			5,000,000		5,000,000		5,000,000
Stated value of each issued share of preferred stock | $ / shares			$ 0.01		$ 0.01		$ 0.01
Amortization of debt discount			$ 44,695		$ 249,702	$ 83,922	$ (2,527)
Remaining debt discount related to warrants			$ 72,200		72,200	0	$ 152,617
Value of common stock issued for services					$ 516,930
Investor
Class of Stock [Line Items]
Maximum number of equity units issued | shares		250,000		1,000,000
Number of investors | Investor		3
Description of equity units				each Unit consists of 1 (one) share of Series A Convertible Preferred Stock
Par value of equity units | $ / unit				0.50
Proceeds from issuance or sale		$ 125,000		$ 500,000
Stated value of each issued share of preferred stock | $ / shares				$ 0.50
Exercise price of warrant | $ / shares				$ 0.50
Warrant exercisable term				1 year
Warrant
Class of Stock [Line Items]
Exercise price of warrant | $ / shares			$ 0.30		$ 0.30
Remaining debt discount related to warrants						$ 0
Common Stock, $0.001 Par Value
Class of Stock [Line Items]
Shares issued price per share (in dollars per share) | $ / shares			$ 0.30		$ 0.30
Common stock issued for services (in shares) | shares					1,299,840
Value of common stock issued for services					$ 1,300
Series A Convertible Preferred Stock, $0.01 Par Value
Class of Stock [Line Items]
Number of investors | Investor	13
Proceeds from issuance or sale	$ 300,000
Shares issued price per share (in dollars per share) | $ / shares	$ 0.40

SHAREHOLDERS' EQUITY (Detail 51

SHAREHOLDERS' EQUITY (Detail Textuals 1)	Jun. 01, 2017USD ($)$ / sharesshares	May 03, 2017shares	Mar. 15, 2017USD ($)Investor$ / sharesshares	Mar. 20, 2017USD ($)$ / sharesshares	Jan. 17, 2017USD ($)$ / sharesshares	Jan. 16, 2017USD ($)$ / sharesshares	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)
Shareholders Equity [Line Items]
Value of common stock issued for services							$ 516,930
Common shares issued for cash							824,000
Repayments of note payable							228,807	$ 2,987
Conversion of preferred stock into common shares							$ 33,238
U.S. accredited investor
Shareholders Equity [Line Items]
Shares issued price per share (in dollars per share) | $ / shares			$ 0.40
Common shares issued for cash (in shares) | shares			2,060,000
Common shares issued for cash			$ 824,000
Number of U.S. accredited investors | Investor			17
Director Agreement | Pawel Hardej
Shareholders Equity [Line Items]
Common stock issued for services (in shares) | shares						145,740
Value of common stock issued for services						$ 64,126
Shares issued price per share (in dollars per share) | $ / shares						$ 0.44
Director Agreement | John Zimmerman
Shareholders Equity [Line Items]
Common stock issued for services (in shares) | shares						41,640
Value of common stock issued for services						$ 18,322
Shares issued price per share (in dollars per share) | $ / shares						$ 0.44
Director Agreement | John Choo
Shareholders Equity [Line Items]
Common stock issued for services (in shares) | shares						62,460
Value of common stock issued for services						$ 27,482
Shares issued price per share (in dollars per share) | $ / shares						$ 0.44
Securities purchase agreement | Firstfire Global Opportunities Fund, LLC
Shareholders Equity [Line Items]
Value of common stock issued for services				$ 100,000
Repayments of note payable				$ 252,917
Conversion of debt, shares issued | shares				333,333
Conversion of stock price per share | $ / shares				$ 0.30
Investor relations consulting agreement
Shareholders Equity [Line Items]
Shares issued price per share (in dollars per share) | $ / shares	$ 0.22
Common shares issued for cash (in shares) | shares	250,000
Common shares issued for cash	$ 55,000
Common stock | Consulting and road show services agreement | Lyons Capital, LLC
Shareholders Equity [Line Items]
Common stock issued for services (in shares) | shares					800,000
Value of common stock issued for services					$ 352,000
Shares issued price per share (in dollars per share) | $ / shares					$ 0.44
Series A Preferred Convertible Stock shareholders ("Series A Holders")
Shareholders Equity [Line Items]
Shares issued price per share (in dollars per share) | $ / shares				0.42
Common shares issued for cash (in shares) | shares		750,000
Conversion of stock price per share | $ / shares				$ 0.30
Number of common stock issued on conversion | shares				416,667
Preferred convertible stock shares issued upon conversion | shares				250,000
Conversion of preferred stock into common shares				$ 175,000

SHAREHOLDERS' EQUITY (Detail 52

SHAREHOLDERS' EQUITY (Detail Textuals 2) - USD ($)	1 Months Ended		6 Months Ended
	Mar. 20, 2017	Sep. 26, 2016	Jun. 30, 2017	Jun. 30, 2016
Shareholders Equity [Line Items]
Repayments of note payable			$ 228,807	$ 2,987
Chuck Rifici Holdings, Inc
Shareholders Equity [Line Items]
Proceeds from notes payable		$ 225,500
Repayments of note payable	$ 225,500	$ 204,000
Original issue discount percentage		10.00%
Number of common stock called by warrants		250,000
Exercise price of warrant		$ 0.30

SUBSEQUENT EVENTS (Detail Textu

SUBSEQUENT EVENTS (Detail Textuals) - shares	Aug. 09, 2017	Aug. 03, 2017	Jun. 30, 2017	Dec. 31, 2016
Subsequent Event [Line Items]
Common stock, shares outstanding			19,323,352	15,213,512
Subsequent Event
Subsequent Event [Line Items]
Common stock, shares outstanding	16,823,352
Subsequent Event | Chad Sykes
Subsequent Event [Line Items]
Shares canceled and returned	2,500,000
Subsequent Event | Alamo Acquisition, LLC
Subsequent Event [Line Items]
Ownership percentage		100.00%

Uncategorized Items - inqd-2017

Label	Element	Value
Series A Convertible Preferred Stock, $0.01 Par Value
Stock Issued During Period, Shares, New Issues	us-gaap_StockIssuedDuringPeriodSharesNewIssues	750,000